Diovan (valsartan) 160 mg per tablet, 7 Tablets per bottle, Rx only Physician Sample Not For Sal...

FDA Drug Recall #D-326-2014 — Class II — August 8, 2013

Recall Summary

Recall Number D-326-2014
Classification Class II — Moderate risk
Date Initiated August 8, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Novartis Pharmaceuticals Corp.
Location Suffern, NY
Product Type Drugs
Quantity 139,788 bottles

Product Description

Diovan (valsartan) 160 mg per tablet, 7 Tablets per bottle, Rx only Physician Sample Not For Sale, Manufactured by: Novartis Pharmaceuticals Corporation Suffern, NY 10901 for Novartis Pharmaceuticals Corporation East Hanover, NJ 07936, NDC # 0078-9359-07

Reason for Recall

Chemical Contamination: Novartis Pharmaceuticals Corporation has recalled physician sample bottles of Diovan, Exforge, Exforge HCT,Lescol XL, Stalevo, Tekturna and Tekturna HCT Tablets due to contamination with Darocur 1173 a photocuring agent used in inks on shrink-wrap sleeves.

Distribution Pattern

Nationwide and Puerto Rico

Lot / Code Information

Product code: 704412; Lot Number: F1186, Exp 03/31/2014; F1127, F1127A, Exp 07/31/2014

Other Recalls from Novartis Pharmaceuticals Corp.

Recall # Classification Product Date
D-1174-2023 Class I SANDIMMUNE Oral Solution (cyclosporine oral sol... Sep 8, 2023
D-1309-2019 Class I Promacta (eltrombopag) 12.5 mg for Oral Suspens... May 11, 2019
D-0678-2017 Class III Isopto Carpine (pilocarpine hydrochloride optha... Mar 22, 2017
D-0679-2017 Class III Pilocarpine Hydrochloride Ophthalmic Solution 4... Mar 22, 2017
D-1430-2015 Class III Dexmethylphenidate HCl Extended-Release, Capsul... Jul 28, 2015

Frequently Asked Questions

Injectable drugs and eye drops must be completely free of microbial contamination because they bypass the body's natural defenses. A contaminated injectable can introduce bacteria or fungi directly into the bloodstream, potentially causing sepsis, meningitis, or localized infections — all of which can be life-threatening. Contamination of sterile products almost always results in a Class I recall. If you received an injectable drug from a recalled lot, contact your healthcare provider immediately, even if you feel well, as some infections can have delayed onset.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.